FDA Approves Safety Labeling Changes for Fluorouracil Injection Products

On March 21, 2024, the US Food and Drug Administration (FDA) approved safety labeling changes for fluorouracil injection products. This effort was a collaboration between FDA’s Office of Generic Drugs and the Oncology Center of Excellence.

For more information read the FDA announcement.

Posted 3/21/2024